Tele-Palliative Care for Graft-versus-Host Disease
(cGVHDTele-PC Trial)

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Massachusetts General Hospital

No Placebo Group

Trial Summary

What is the purpose of this trial?This research study is evaluating the feasibility and acceptability of implementing a telehealth palliative care intervention in patients with moderate to severe chronic graft-versus-host disease.

Eligibility Criteria

This trial is for adults over 18 with moderate to severe chronic graft-versus-host disease (cGVHD) as assessed by their oncologist. Participants must understand and speak English well enough to answer questions. Those with acute psychiatric or cognitive conditions, or who are already in palliative care, cannot join.

Inclusion Criteria

My doctor has diagnosed me with moderate to severe chronic graft-versus-host disease.

I am over 18 years old.

Ability to comprehend and speak English, and to read and respond to questions in English

Exclusion Criteria

Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believe prohibits informed consent or compliance with study procedures

I am currently receiving or have received palliative care.

Participant Groups

The study is testing the use of telehealth for providing palliative care to patients suffering from cGVHD. It aims to determine how practical and acceptable it is for patients to receive this type of remote healthcare service.

1Treatment groups

Experimental Treatment

Group I: Tele-PC InterventionExperimental Treatment1 Intervention

Participants (individuals with moderate to severe chronic Graft-versus-Host Disease) will receive a monthly at home consultation with a specialty palliative care clinician via a video-conference tele-health visit.